Trials / Recruiting
RecruitingNCT06493968
Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With PASD Undergoing Cesarean Hysterectomy
Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With Placenta Accrete Spectrum Disorders Undergoing Cesarean Hysterectomy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Objectives: To evaluate the effect of oxytocin in reducing intraoperative blood loss in patients with PAS disorders planned for cesarean hysterectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oxytocin | Uterotonics will be given in the form of an IV bolus of 10 units of oxytocin immediately with the uterine incision |
| OTHER | placebo | IV bolus of normal saline immediately with the uterine incision |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2024-07-10
- Last updated
- 2024-07-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06493968. Inclusion in this directory is not an endorsement.